Evidence map›Paper›PMID 42494793›Full record

ReviewJournal of tissue engineering

Integrating single-cell and spheroid strategies in tissue engineering: Comparative insights from pancreas, cartilage, heart and brain.

Shankar Shanmuga Sundaram, Michelle Min Shuen Tan, Quang Bach Le, Wei Seong Toh, Deepak Choudhury

Abstract readReview
In one paragraph

Review in Journal of tissue engineering. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shankar Shanmuga SundaramBioengineering & Automation (BE&A), Bioprocessing Technology Institute (BTI), Agency for Science, Technology, and Research (A STAR), Singapore.ORCID https://orcid.org/0009-0000-4134-5433
Michelle Min Shuen TanBioengineering & Automation (BE&A), Bioprocessing Technology Institute (BTI), Agency for Science, Technology, and Research (A STAR), Singapore.ORCID https://orcid.org/0009-0006-3414-9630
Quang Bach LeBioengineering & Automation (BE&A), Bioprocessing Technology Institute (BTI), Agency for Science, Technology, and Research (A STAR), Singapore.ORCID https://orcid.org/0000-0002-1001-4751
Wei Seong TohDepartment of Orthopaedic Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.ORCID https://orcid.org/0000-0001-9147-6423
Deepak ChoudhuryBioengineering & Automation (BE&A), Bioprocessing Technology Institute (BTI), Agency for Science, Technology, and Research (A STAR), Singapore.ORCID https://orcid.org/0000-0001-9609-1346

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tissue engineering (TE) remains a cornerstone of regenerative medicine, aiming to bypass the limitation of organ transplantation through the fabrication of functional tissue substitutes. Traditionally, TE has followed two primary paradigms: the top-down approach, utilising single cells seeded on a scaffold, and the bottom-up approach, employing cell spheroids as building blocks. While top-down offers architectural and structural control, bottom-up promotes self-assembly, native-like extracellular matrix deposition, and intercellular signalling. However, modern techniques increasingly blur this dichotomy, creating a spectrum of cell-based fabrication approaches. This review evaluates the diverse approaches across four major tissue classes: epithelial (pancreas as an example), connective (cartilage), muscle (heart), and nervous (brain) tissues. For each tissue, we examine notable studies to evaluate how different assembly methods recapitulate native tissue properties. By reviewing case studies across diverse tissue types, we highlight the relative strengths and limitations of various fabrication strategies. Although this review is limited by a selective cross-section of literature within a rapidly advancing technological landscape, it provides critical insights into optimising next-generation tissue constructs. In conclusion, we posit that there is no universal fabrication strategy; rather, the future of the field depends on tailoring approaches along this single-cell-to-spheroid spectrum based on the specific architectural and functional demands of the target tissue.

Indexed as

bioengineeringbraincartilagecell spheroidsheartorganoidspancreasregenerative medicinetissue constructstissue engineering

Identifiers

PMID42494793
PMCPMC13392336

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.